DiagnaMed Launches PalGPT.ai, a Generative AI Brain Health Solution
TORONTO, May 25, 2023 (GLOBE NEWSWIRE) — DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB:DGNMF), a generative AI healthcare solutions company, is pleased to announce the launch of PalGPT.ai (https://palgpt.ai), a generative AI brain health solution powered by OpenAI’s ChatGPT for people seeking an AI companion to have meaningful private conversations, friendly advice and share inner thoughts. PalGPT.ai is the Company’s second commercial product from its Health GenAI division, which is focused on the development and commercialization of a suite of generative AI ready-made and customizable applications to support the healthcare market in improving patient outcomes, operational workflow and efficiency.
Related news for (DGNMF)
- DiagnaMed Offering its Brain Health AI Platform for Investigating Weight Loss Drugs, such as Semaglutide (GLP-1), on Brain Function
- DiagnaMed Cancels Previously Announced Private Placement
- DiagnaMed Announces LIFE Offering of up to $650,000
- DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI
- DiagnaMed Adds New Launch Site of CERVAI™ Brain Health AI